You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your inbox on Tuesdays and Thursdays.
Does the shutdown actually stall price negotiations?
There are a slew of government health programs and thousands of federal staff that could see work stalled by the budget deadline Friday. But is Biden’s signature drug pricing program on the outs too?
HHS Secretary Xavier Becerra warned reporters Friday that “a lot” of the work negotiation staff are doing right now — compiling information, corresponding with manufacturers — “takes people who would be impacted by a shutdown.”
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect